Concepedia

C R Divgi

CR

Statistics

Publications

3

Citations

314

H-Index

3

Active since

1996

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

C R Divgi is an author at Memorial Sloan Kettering Cancer Center specializing in nuclear medicine, medicine, and iodine-131 radiopharmaceuticals.

Publications per year

1996–1998

3

Publications

3

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.

S Welt, Andrew M. Scott, C R Divgi et al. · Journal of Clinical Oncology · 1996 · 226 citations

, , +17

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Susan F. Slovin, Howard I. Scher, C R Divgi et al. · PubMed · 1998 · 66 citations

, , +17

Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration.

A M El-Shirbiny, S S Stavrou, Ann M. Dnistrian et al. · PubMed · 1997 · 22 citations

, , +17

1–3 of 3